G. Solbu
AuthID: R-00H-9QE
1
TITLE: Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/ macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: Final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group Full Text
AUTHORS: Zwierzina, H; Suciu, S; Loeffler Ragg, J; Neuwirtova, R; Fenaux, P; Beksac, M; Harousseau, J; Nuessler, V; Cermak, J; Solbu, G; Willemze, R; de Witte, T; Amadori, S; Stryckmans, P; Bron, D; Louwagie, A; Selleslag, D; Peetermans, M; Berneman, Z; Coiffier, B; ...More
PUBLISHED: 2005, SOURCE: Leukemia, VOLUME: 19, ISSUE: 11
AUTHORS: Zwierzina, H; Suciu, S; Loeffler Ragg, J; Neuwirtova, R; Fenaux, P; Beksac, M; Harousseau, J; Nuessler, V; Cermak, J; Solbu, G; Willemze, R; de Witte, T; Amadori, S; Stryckmans, P; Bron, D; Louwagie, A; Selleslag, D; Peetermans, M; Berneman, Z; Coiffier, B; ...More
PUBLISHED: 2005, SOURCE: Leukemia, VOLUME: 19, ISSUE: 11
INDEXED IN: 
Scopus 
CrossRef
Scopus CrossRef